Transplant Tolerance to Pancreatic Islets Is Initiated in the Graft and Sustained in the Spleen

The immune system is comprised of several CD4+ T regulatory (Treg) cell types, of which two, the Foxp3+ Treg and T regulatory type 1 (Tr1) cells, have frequently been associated with transplant tolerance. However, whether and how these two Treg‐cell types synergize to promote allograft tolerance remains unknown. We previously developed a mouse model of allogeneic transplantation in which a specific immunomodulatory treatment leads to transplant tolerance through both Foxp3+ Treg and Tr1 cells. Here, we show that Foxp3+ Treg cells exert their regulatory function within the allograft and initiate engraftment locally and in a non‐antigen (Ag) specific manner. Whereas CD4+CD25− T cells, which contain Tr1 cells, act from the spleen and are key to the maintenance of long‐term tolerance. Importantly, the role of Foxp3+ Treg and Tr1 cells is not redundant once they are simultaneously expanded/induced in the same host. Moreover, our data show that long‐term tolerance induced by Foxp3+ Treg‐cell transfer is sustained by splenic Tr1 cells and functionally moves from the allograft to the spleen.

[1]  B. Burrell,et al.  Fates of CD4+ T Cells in a Tolerant Environment Depend on Timing and Place of Antigen Exposure , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  M. Atkinson,et al.  Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation , 2011, PloS one.

[3]  F. Regateiro,et al.  Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance , 2011, The Journal of experimental medicine.

[4]  Francis J. Huber,et al.  Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.

[5]  J. Prieto,et al.  A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice , 2010, The Journal of Immunology.

[6]  L. Turka,et al.  An update on regulatory T cells in transplant tolerance and rejection , 2010, Nature Reviews Nephrology.

[7]  V. Kuchroo,et al.  Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. , 2010, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[8]  V. Serre-Beinier,et al.  Anti-CD154 mAb and Rapamycin Induce T Regulatory Cell Mediated Tolerance in Rat-to-Mouse Islet Transplantation , 2010, PloS one.

[9]  Dan R. Littman,et al.  Th17 and Regulatory T Cells in Mediating and Restraining Inflammation , 2010, Cell.

[10]  Y. Belkaid,et al.  Regulatory ripples , 2010, Nature Immunology.

[11]  M. Atkinson,et al.  Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet Transplant , 2009, Diabetes.

[12]  C. Benoist,et al.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes , 2009, Nature Immunology.

[13]  Meenu R Pillai,et al.  The development and function of regulatory T cells , 2009, Cellular and Molecular Life Sciences.

[14]  J. Sprent,et al.  In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression , 2009, The Journal of experimental medicine.

[15]  R. Jessberger,et al.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. , 2009, Immunity.

[16]  Aaron J. Martin,et al.  ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.

[17]  W. Weimar,et al.  Regulatory T cells after organ transplantation: where does their action take place? , 2008, Human immunology.

[18]  R. Selvaraj,et al.  Mitigation of Experimental Allergic Encephalomyelitis by TGF-β Induced Foxp3+ Regulatory T Lymphocytes through the Induction of Anergy and Infectious Tolerance1 , 2008, The Journal of Immunology.

[19]  Qizhi Tang,et al.  The Foxp3+ regulatory T cell: a jack of all trades, master of regulation , 2008, Nature Immunology.

[20]  Kathryn M. Jones,et al.  Despite Increased CD4+Foxp3+ Cells within the Infection Site, BALB/c IL-4 Receptor-Deficient Mice Reveal CD4+Foxp3-Negative T Cells as a Source of IL-10 in Leishmania major Susceptibility1 , 2007, The Journal of Immunology.

[21]  A. Rudensky,et al.  Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3− precursor cells in the absence of interleukin 10 , 2007, Nature Immunology.

[22]  F. Sutterwala,et al.  Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. , 2006, Immunity.

[23]  Katharina Fleischhauer,et al.  Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans , 2006, Immunological reviews.

[24]  E. Bonifacio,et al.  Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells , 2006, Diabetes.

[25]  M. Baumgart,et al.  Naturally Occurring CD4+Foxp3+ Regulatory T Cells Are an Essential, IL-10-Independent Part of the Immunoregulatory Network in Schistosoma mansoni Egg-Induced Inflammation , 2006, The Journal of Immunology.

[26]  E. Bonifacio,et al.  Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. , 2006, Diabetes.

[27]  T. Geiger,et al.  IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Hyun-Hee Lee,et al.  IL-10 Diminishes CTLA-4 Expression on Islet-Resident T Cells and Sustains Their Activation Rather Than Tolerance1 , 2005, The Journal of Immunology.

[29]  G. Schuler,et al.  Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells , 2002, The Journal of experimental medicine.

[30]  H. Yagita,et al.  In vivo roles of donor and host dendritic cells in allogeneic immune response: cluster formation with host proliferating T cells , 2001, Journal of leukocyte biology.

[31]  N. Sinclair CTLA-4 up-regulation plays a role in tolerance mediated by CD45 , 2001, Nature Immunology.

[32]  S. Smith,et al.  Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. , 1995, Blood.

[33]  N. Sarvetnick,et al.  Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans , 1993, The Journal of experimental medicine.